参考文献/References:
[1] Hahn SY,Shin JH,Na DG,et al.Ethanol ablation of the thyroid nodules:2018 Consensus Statement by the Korean Society of Thyroid Radiology[J].Korean J Radiol,2019,20(4):609-620.DOI:10.3348/kjr.2018.0696.
[2] Park HS,Yim Y,Baek JH,et al.Ethanol ablation as a treatment strategy for benign cystic thyroid nodules:a comparison of the ethanol retention and aspiration techniques[J].Ultrasonography,2019,38(2):166-171.DOI:10.14366/usg.18033.
[3] Cho W,Sim JS,Jung SL.Ultrasound-guided ethanol ablation for cystic thyroid nodules:effectiveness of small amounts of ethanol in a single session[J].Ultrasonography,2021,40(3):417-427.DOI:10.14366/usg.20170.
[4] Yim Y,Baek JH,Chung SR,et al.Recurrence and additional treatment of cystic thyroid nodules after ethanol ablation:validation of three proposed criteria[J].Ultrasonography,2021,40(3):378-386.DOI:10.14366/usg.20039.
[5] Basu N,Dutta D,Maisnam I,et al.Percutaneous ethanol ablation in managing predominantly cystic thyroid nodules:an eastern India perspective[J].Indian J Endocrinol Metab,2014,18(5):662-668.DOI:10.4103/2230-8210.139229.
[6] Kim JH,Baek JH,Lim HK,et al; Guideline Committee for the Korean Society of Thyroid Radiology(KSThR)and Korean Society of Radiology.2017 Thyroid Radiofrequency Ablation Guideline:Korean Society of Thyroid Radiology[J].Korean J Radiol,2018,19(4):632-655.DOI:10.3348/kjr.2018.19.4.632.
[7] Deandrea M,Trimboli P,Creanza A,et al.Long-term follow-up of cystic thyroid nodules treated with percutaneous ethanol injection(PEI)using two different approaches[J].Eur J Endocrinol,2020,183(5):489-495.DOI:10.1530/EJE-20-0213.
[8] Suh CH,Baek JH,Ha EJ,et al.Ethanol ablation of predominantly cystic thyroid nodules:evaluation of recurrence rate and factors related to recurrence[J].Clin Radiol,2015,70(1):42-47.DOI:10.1016/j.crad.2014.09.008.
[9] Gharib H,Hegedüs L,Pacella CM,et al.Clinical review:nonsurgical,image-guided,minimally invasive therapy for thyroid nodules[J].J Clin Endocrinol Metab,2013,98(10):3949-3957.DOI:10.1210/jc.2013-1806.
[10] 陈茉,徐书杭,许洋,等.经皮微波消融治疗良性无功能甲状腺结节疗效和超声形态分析[J].国际内分泌代谢杂志,2019,39(5):294-297,301.DOI:10.3760/cma.j.issn.1673-4157.2019.05.002.
[11] Papini E,Monpeyssen H,Frasoldati A,et al.2020 European Thyroid Association Clinical Practice Guideline for the Use of Image-Guided Ablation in Benign Thyroid Nodules[J].Eur Thyroid J,2020,9(4):172-185.DOI:10.1159/000508484.
[12] He L,Zhao W,Xia Z,et al.Comparative efficacy of different ultrasound-guided ablation for the treatment of benign thyroid nodules:systematic review and network meta-analysis of randomized controlled trials[J].PLoS One,2021,16(1):e0243864.DOI:10.1371/journal.pone.0243864.
[13] Yang CC,Hsu Y,Liou JY.Efficacy of ethanol ablation for benign thyroid cysts and predominantly cystic nodules:a systematic review and meta-analysis[J].Endocrinol Metab(Seoul),2021,36(1):81-95.DOI:10.3803/EnM.2020.833.
[14] Baek JH,Ha EJ,Choi YJ,et al.Radiofrequency versus ethanol ablation for treating predominantly cystic thyroid nodules:a randomized clinical trial[J].Korean J Radiol,2015,16(6):1332-1340.DOI:10.3348/kjr.2015.16.6.1332.
[15] 朱亚琼,金壮,张颖,等.无水乙醇提高甲状腺良性实性结节射频消融治疗效率的前瞻性随机对照研究[J].中国医学科学院学报,2020,42(3):331-337.DOI:10.3881/j.issn.1000-503X.11512.
[16] Su C,Liu YJ,Qian LX.Modified percutaneous ethanol injection method combined with microwave ablation for the treatment of symptomatic,predominantly cystic,benign thyroid nodules:a retrospective study of 201 cases[J].Int J Hyperthermia,2021,38(1):995-1001.DOI:10.1080/02656736.2021.1924407.
[17] Negro R,Greco G.Percutaneous ethanol injection in combination with laser ablation for a 100 ml partially cystic thyroid nodule[J].Case Rep Endocrinol,2018,2018:8046378.DOI:10.1155/2018/8046378.
[18] Lang BHH,Woo YC,Chiu KW.Combining high-intensity focused ultrasound(HIFU)ablation with percutaneous ethanol injection(PEI)in the treatment of benign thyroid nodules[J].Eur Radiol,2021,31(4):2384-2391.DOI:10.1007/s00330-020-07317-3.
[19] Hay ID,Lee RA,Kaggal S,et al.Long-term results of treating with ethanol ablation 15 adult patients with cT1aN0 papillary thyroid microcarcinoma[J].J Endocr Soc,2020,4(11):bvaa135.DOI:10.1210/jendso/bvaa135.
[20] Lu C,Li X,Chu X,et al.Clinical effects of microwave ablation in the treatment of low-risk papillary thyroid microcarcinomas and related histopathological changes[J].Front Endocrinol(Lausanne),2021,12:751213.DOI:10.3389/fendo.2021.751213.
[21] Jeong SY,Baek JH,Choi YJ,et al.Ethanol and thermal ablation for malignant thyroid tumours[J].Int J Hyperthermia,2017,33(8):938-945.DOI:10.1080/02656736.2017.1361048.
[22] Suh CH,Baek JH,Choi YJ,et al.Efficacy and safety of radiofrequency and ethanol ablation for treating locally recurrent thyroid cancer:a systematic review and meta-analysis[J].Thyroid,2016,26(3):420-428.DOI:10.1089/thy.2015.0545.
[23] Guenette JP,Monchik JM,Dupuy DE.Image-guided ablation of postsurgical locoregional recurrence of biopsy-proven well-differentiated thyroid carcinoma[J].J Vasc Interv Radiol,2013,24(5):672-679.DOI:10.1016/j.jvir.2013.02.001.
相似文献/References:
[1]杨成会,缪珩.二甲双胍在甲状腺疾病治疗中的作用[J].国际内分泌代谢杂志,2015,(04):255.[doi:10.3760/cma.j.issn.1673-4157.2015.04.011]
Yang Chenghui,Miao Heng..Roles of metformin in the treatment of thyroid diseases[J].International Journal of Endocrinology and Metabolism,2015,(06):255.[doi:10.3760/cma.j.issn.1673-4157.2015.04.011]
[2]张蓉,俞立波,李连喜.组蛋白修饰与甲状腺癌[J].国际内分泌代谢杂志,2014,(05):348.[doi:10.3760/cma.j.issn.1673-4157.2014.05.017]
Zhang Rong,Yu Libo,Li Lianxi..Histone modification and thyroid tumor[J].International Journal of Endocrinology and Metabolism,2014,(06):348.[doi:10.3760/cma.j.issn.1673-4157.2014.05.017]
[3]梁绮君 余寿益 李淑华 胡晨鸣 杨焱.甲状腺结节与代谢综合征的相关性研究[J].国际内分泌代谢杂志,2015,(05):293.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.002]
Liang Qijun,Yu Shouyi,Li Shuhua,et al.Association of thyroid nodule and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2015,(06):293.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.002]
[4]李兴佳,徐书杭,刘超.雌激素及其受体与甲状腺癌的关系[J].国际内分泌代谢杂志,2016,36(04):273.[doi:10.3760/cma.j.issn.1673-4157.2016.04.15]
Li Xingjia,Xu Shuhang,Liu Chao.Relationship between estrogen, its receptors and thyroid cancer[J].International Journal of Endocrinology and Metabolism,2016,36(06):273.[doi:10.3760/cma.j.issn.1673-4157.2016.04.15]
[5]郑仁东,刘超.白细胞介素-6与甲状腺疾病[J].国际内分泌代谢杂志,2016,36(05):352.[doi:10.3760/cma.j.issn.1673-4157.2016.05.18]
Zheng Rendong,Liu Chao.Interleukin-6 and thyroid disease[J].International Journal of Endocrinology and Metabolism,2016,36(06):352.[doi:10.3760/cma.j.issn.1673-4157.2016.05.18]
[6]郑仁东,刘超.STAT3与甲状腺肿瘤[J].国际内分泌代谢杂志,2017,37(05):345.
Zheng Rendong,Liu Chao..STAT3 and thyroid tumor[J].International Journal of Endocrinology and Metabolism,2017,37(06):345.
[7]郑仁东 张会峰 胡咏新 曹雯 曹琳 孙洪平 褚晓秋 刘克冕 刘超.男性2型糖尿病患者甲状腺结节
与内分泌激素的相关性研究[J].国际内分泌代谢杂志,2018,38(04):222.[doi:10.3760/cma.j.issn.1673-4157.2018.04.002]
Zheng Rendong,Zhang Huifeng,Hu Yongxin,et al.Association of thyroid nodules with endocrine hormones in male patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2018,38(06):222.[doi:10.3760/cma.j.issn.1673-4157.2018.04.002]
[8]孟祥慧 徐书杭 陈国芳 刘超.二甲双胍在甲状腺癌防治中的作用[J].国际内分泌代谢杂志,2018,38(04):237.[doi:10.3760/cma.j.issn.1673-4157.2018.04.005]
Meng Xianghui*,Xu Shuhang,Chen Guofang,et al.Role of metformin in prevention and treatment of thyroid cancer[J].International Journal of Endocrinology and Metabolism,2018,38(06):237.[doi:10.3760/cma.j.issn.1673-4157.2018.04.005]
[9]曹星月 武晓泓.基因拷贝数异常在甲状腺癌诊断和预后判断中的
应用进展[J].国际内分泌代谢杂志,2019,39(01):29.[doi:10.3760/cma.j.issn.1673-4157.2019.01.007]
Cao Xingyue,Wu Xiaohong.Progress in the application of gene copy number variations in diagnosis and prognosis of thyroid cancer[J].International Journal of Endocrinology and Metabolism,2019,39(06):29.[doi:10.3760/cma.j.issn.1673-4157.2019.01.007]
[10]张会峰 胡天赤 陈学勤 叶向荣 刘超.丙型肝炎病毒感染与自身免疫性甲状腺疾病
及甲状腺癌风险[J].国际内分泌代谢杂志,2019,39(02):128.[doi:10.3760/cma.j.issn.1673-4157.2019.02.014]
Zhang Huifeng,Hu Tianchi,Chen Xueqin,et al.Relationship between hepatitis C virus infection and the risk of autoimmune thyroid diseases and thyroid cancer[J].International Journal of Endocrinology and Metabolism,2019,39(06):128.[doi:10.3760/cma.j.issn.1673-4157.2019.02.014]
[11]田勍,洪天配.甲状腺结节诊治过程中的难点与应对[J].国际内分泌代谢杂志,2021,41(06):557.[doi:10.3760/cma.j.cn121383-20210727-07074]
Tian Qing,Hong Tianpei..Difficulties and countermeasures in the diagnosis and treatment of thyroid nodules[J].International Journal of Endocrinology and Metabolism,2021,41(06):557.[doi:10.3760/cma.j.cn121383-20210727-07074]